The poultry antibiotic market is estimated to be valued at US$ 2.0 Bn in 2023 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The poultry antibiotic market consists of products used to prevent or treat diseases in poultry animals such as chickens and turkeys. Some common antibiotics used in poultry feed include tetracyclines, penicillins, macrolides, aminoglycosides, and sulfonamides. They help promote growth and improve feed efficiency in poultry.

Market Dynamics:
The demand for poultry antibiotic is rising due to increasing consumption of poultry meat and eggs globally. Growing population and rising income levels in developing regions of Asia Pacific and Latin America are fueling the demand for antibiotic-raised poultry. Additionally, factors such as small living spaces for poultry farms and high transmission of diseases among confined poultry populations have increased the reliance on antibiotics for disease prevention and growth promotion in commercial poultry farming. However, overuse of antibiotics can lead to antimicrobial resistance which may threaten human and animal health. Thus, regulating the use of antibiotics in animal feed and increasing the demand for antibiotic-free poultry are some of the factors expected to restraint the market growth over the forecast period.

SWOT Analysis
Strength: The poultry antibiotics market has strong growth potential due to rising meat consumption. Poultry antibiotics help increase feed conversion rates and ensures better health of poultry. The market players are focusing on development of novel and more effective antibiotics which is strengthening their product portfolio.

Weakness: Strict government regulations regarding the use of antibiotics in poultry industry can hamper the market growth. Overuse of antibiotics leads to development of antimicrobial resistance which is a major concern.

Opportunity: Emerging economies offer lucrative opportunities for market players due to growing meat demand. Advancements in drug discovery and vaccine development will create new opportunities in the market.

Threats: Threat of substitutes like probiotics and prebiotics can replace the use of antibiotics in poultry industry. Rise in awareness about adverse effects of antibiotic residue in meat can negatively impact the demand.

Key Takeaways
The global poultry antibiotic market is expected to witness high growth, exhibiting CAGR of 6.0% over the forecast period, due to increasing meat consumption worldwide. Rising disposable income and changing dietary habits are major drivers for growing demand of poultry meat. According to FAO, global meat production is projected to increase by over 73% between 2010 and 2050 to meet the demand.

Regional analysis North America dominates the global poultry antibiotics market share owing to large production and consumption of poultry meat in the US and Canada. Europe accounts for the second largest market due to well established poultry industry. However, Asia Pacific is expected to exhibit highest growth rate due to rising meat exports from China and India.

Key players operating in the poultry antibiotics market are Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck Co. Inc., Bayer AG, Ceva Santé Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Huvepharma, Neogen Corporation, Nisseiken Co., Ltd., Venkys India Ltd., Inovio Pharmaceuticals, Inc. The market is highly competitive with focus on development of novel products. Mergers acquisitions are key strategies adopted by companies to strengthen their market position.